Latest Articles Page 142 of 355
-
Perspective March 17, 2023
P.1-2
J RNAi Gene Silencing: 19(2): 1-2
Transcriptomics as a tool in studying cellular phenotype.
Author(s): Martina Semenzin*
-
Opinion Article March 17, 2023
P.1-2
J RNAi Gene Silencing: 19(2): 1-2
Exploring metagenomics: Applications and future directions.
Author(s): Marais Gellman*
-
Perspective March 17, 2023
P.1-1
J RNAi Gene Silencing: 19(2): 1-1
Mitochondrial DNA and the origins of life.
Author(s): Stephen Finnie*
-
Short Communication March 17, 2023
P.1-2
J RNAi Gene Silencing: 19(2): 1-2
Traditional genome modulation technologies.
Author(s): Melanie Saccenti*
-
Opinion Article March 17, 2023
P.1-1
J RNAi Gene Silencing: 19(2): 1-1
The importance of genome analysis in understanding human health and disease.
Author(s): Mathias Winkler*
-
Opinion Article March 17, 2023
P.1-1
J RNAi Gene Silencing: 19(2): 1-1
Exploring the capitivity of epigenomics.
Author(s): Pascale Bakker*
-
Perspective March 17, 2023
P.1-1
J RNAi Gene Silencing: 19(2): 1-1
The adaptability of ribozymes in gene regulation.
Author(s): Miriam Silva*
-
Perspective March 17, 2023
P.1-1
J RNAi Gene Silencing: 19(2): 1-1
The function, expression and regulation of genes.
Author(s): Yingwen Fu*
-
Mini Review April 29, 2023
P.1-2
J Cancer Immunol Ther: 6(2): 1-2
The role of tumor microenvironment in cancer immunology.
Author(s): Stevens Siegel
-
Rapid Communication April 26, 2023
P.1-2
J Cancer Immunol Ther: 6(2): 1-2
Brief note on alternative and complementary therapies for leiomyosarcoma.
Author(s): Sophie Heilig*